REDWOOD MORTGAGE INVESTORS VIII Financial Statements (2025 and earlier)
Company Profile
| Business Address |
177 BOVET ROAD SAN MATEO, CA 94402 |
| State of Incorp. | CA |
| Fiscal Year End | December 31 |
| Industry (SIC) | 65 - Real Estate (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 963 | 3,903 | 364 | 4,142 | 13,607 | 1,723 | |||
| Cash and cash equivalent | 963 | 3,903 | 364 | 4,142 | 13,607 | 1,723 | |||
| Deferred costs | 49 | 87 | 59 | 50 | 113 | 124 | |||
| Total current assets: | 1,012 | 3,990 | 423 | 4,192 | 13,720 | 1,847 | |||
| Noncurrent Assets | |||||||||
| Other noncurrent assets | |||||||||
| Total noncurrent assets: | |||||||||
| Other undisclosed assets | 66,181 | 64,380 | 83,898 | 90,162 | 102,003 | 138,686 | |||
| TOTAL ASSETS: | 67,193 | 68,370 | 84,321 | 94,354 | 115,723 | 140,533 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,100 | ||||||||
| Accrued liabilities | 1,100 | ||||||||
| Debt | 10,000 | 2,453 | |||||||
| Total current liabilities: | 11,100 | 2,453 | |||||||
| Noncurrent Liabilities | |||||||||
| Other undisclosed liabilities | 1,788 | 2,802 | 3,515 | 388 | 162 | ||||
| Total liabilities: | 12,888 | 2,802 | 5,968 | 388 | 162 | ||||
| Equity | |||||||||
| Other undisclosed equity | 54,305 | 65,568 | 78,353 | 115,335 | 140,371 | ||||
| Total equity: | 54,305 | 65,568 | 78,353 | 115,335 | 140,371 | ||||
| Other undisclosed liabilities and equity | 94,354 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 67,193 | 68,370 | 84,321 | 94,354 | 115,723 | 140,533 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 4,668 | 6,648 | 6,943 | 7,925 | 9,395 | 9,444 | ||
| Cost of revenue | (5) | (603) | ||||||
| Cost of product and service sold | (603) | |||||||
| Provision for loan, lease, and other losses | (5) | ✕ | ||||||
| Gross profit: | 4,668 | 6,643 | 6,943 | 7,925 | 9,395 | 8,841 | ||
| Operating expenses | (3,011) | (3,714) | (3,629) | (5,007) | (4,350) | (5,431) | ||
| Other operating income (expense), net | 43 | (24) | ||||||
| Operating income: | 1,657 | 2,972 | 3,290 | 2,918 | 5,045 | 3,410 | ||
| Nonoperating income (Investment Income, Nonoperating) | 7,055 | 6,977 | ||||||
| Interest and debt expense | (574) | (464) | (143) | |||||
| Income (loss) from continuing operations: | 1,083 | 9,563 | 10,124 | 2,918 | 5,045 | 3,410 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | 9,563 | 10,124 | 2,918 | 5,045 | 3,410 | |
| Other undisclosed net income (loss) | 574 | (6,634) | (6,676) | 1,563 | 13 | 1,213 | ||
| Net income (loss): | 1,657 | 2,929 | 3,448 | 4,481 | 5,058 | 4,623 | ||
| Other undisclosed net income attributable to parent | ||||||||
| Net income available to common stockholders, diluted: | 1,657 | 2,929 | 3,448 | 4,481 | 5,058 | 4,623 | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 1,657 | 2,929 | 3,448 | 4,481 | 5,058 | 4,623 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 1,657 | 2,929 | 3,448 | 4,481 | 5,058 | 4,623 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.